strain
escherichia
coli
klebsiella
pneumonia
caus
septicemia
like
origin
gut
relationship
gut
microbiota
develop
viral
infect
howev
well
describ
studi
mice
shown
relationship
gut
microbiota
impair
viral
clearanc
abt
et
al
investig
antibiot
administr
mous
model
lymphocyt
choriomening
viru
found
antibiot
administr
led
decreas
innat
viral
immun
respons
well
delay
clearanc
studi
reveal
butyr
product
certain
gut
anaerob
bacteria
immunomodulatori
role
contribut
overal
health
distant
site
lung
haak
et
al
investig
role
butyrateproduc
gut
bpg
bacteria
futur
develop
viral
infect
cohort
allogen
hsct
recipi
report
rel
gut
abund
bpg
bacteria
associ
less
futur
develop
lower
respiratori
viral
infect
base
upon
studi
profil
gut
microbiota
use
rrna
gene
sequenc
region
fecal
specimen
kidney
transplant
recipi
report
rel
abund
bpg
bacteria
associ
less
risk
develop
respiratori
viral
infect
kidney
transplant
recipi
provid
support
find
haak
et
al
studi
kidney
transplant
recipi
provid
fecal
specimen
use
fisherbrand
commod
specimen
collect
kit
thermo
fisher
scienc
fecal
specimen
aliquot
approxim
mg
aliquot
subsequ
store
recipi
ask
provid
specimen
posttranspl
week
dna
extract
rrna
gene
amplif
rrna
gene
region
perform
describ
lee
et
al
sequenc
pcr
amplicon
perform
illumina
miseq
platform
base
pair
base
pair
bioinformat
taxonom
classif
perform
describ
lee
et
al
briefli
taxonomi
determin
use
nucleotid
blast
refer
train
set
ncbi
refseq
minimum
evalu
threshold
distribut
continu
variabl
analyz
use
twotail
wilcoxon
ranksum
test
unpair
valu
twotail
wilcoxon
signedrank
test
pair
valu
distribut
categor
variabl
analyz
use
twotail
fisher
exact
test
cox
regress
hazard
model
use
estim
whether
rel
gut
abund
bpg
bacteria
associ
decreas
risk
develop
respiratori
viru
infect
cmv
viremia
bk
viremia
surviv
curv
construct
compar
use
logrank
test
analys
perform
r
rstudio
among
fecal
specimen
kidney
transplant
recipi
mean
standard
deviat
amount
high
qualiti
rrna
bacteri
gene
sequenc
overal
demograph
transplant
characterist
subject
present
tabl
bpg
speci
speci
detect
tabl
sum
rel
gut
abund
bpg
bacteria
calcul
fecal
specimen
defin
hereaft
rel
gut
abund
bpg
bacteria
mean
rel
gut
abund
bpg
bacteria
among
fecal
specimen
standard
deviat
top
bpg
speci
faecalibacterium
prausnitzii
mean
holdemanella
biformi
eubacterium
dolichum
coprococcu
come
subdoligranulum
variabil
eubacterium
rectal
heatmap
rel
gut
abund
top
speci
among
fecal
specimen
present
figur
f
g
u
r
e
heatmap
top
abund
butyrateproduc
gut
bacteria
kidney
transplant
cohort
fecal
specimen
kidney
transplant
recipi
repres
xaxi
top
butyrateproduc
gut
speci
yaxi
rel
abund
speci
repres
blue
logscal
mark
variabl
top
butyrateproduc
speci
among
specimen
signedrank
test
figur
next
evalu
subgroup
subject
pair
abx
group
receiv
anaerob
antibiot
coverag
anaerob
antibiot
coverag
includ
follow
antibiot
metronidazol
carbapenem
clindamycin
combin
penicillin
betalactamas
inhibitor
oral
vancomycin
rational
evalu
antibiot
anaerob
coverag
base
strict
anaerob
natur
mani
bpg
bacteria
eg
faecalibacterium
prausnitzii
eubacterium
rectal
among
pair
abx
group
subject
anaerob
antibiot
coverag
signific
decreas
rel
gut
abund
bpg
bacteria
posttranspl
week
posttranspl
week
median
vs
respect
p
wilcoxon
signedrank
test
figur
also
evalu
whether
rel
gut
abund
bpg
bacteria
associ
gender
age
greater
year
old
african
american
race
induct
therapi
steroid
mainten
therapi
kidney
function
month
post
transplant
antibiot
associ
decreas
abund
bpg
bacteria
evalu
pair
specimen
subject
receiv
antibiot
posttranspl
week
posttranspl
abund
butyrateproduc
gut
bacteria
time
kidney
transplant
cohort
panel
point
repres
singl
fecal
specimen
day
specimen
produc
xaxi
rel
gut
abund
butyrateproduc
gut
bpg
bacteria
yaxi
line
repres
local
estim
scatterplot
smooth
loess
curv
confid
interv
indic
shade
band
panel
b
point
repres
singl
fecal
specimen
day
specimen
produc
xaxi
rel
gut
abund
butyrateproduc
gut
bpg
bacteria
yaxi
point
blue
repres
individu
fecal
specimen
specimen
patient
abx
group
point
magenta
repres
individu
fecal
specimen
specimen
patient
abx
group
line
repres
loess
curv
confid
interv
indic
shade
band
panel
c
box
whisker
plot
rel
gut
abund
bpg
bacteria
yaxi
fecal
specimen
posttranspl
week
xaxi
subject
pair
abx
group
box
whisker
plot
line
repres
median
edg
box
plot
whisker
time
median
point
repres
outlier
p
valu
calcul
use
wilcoxon
signedrank
test
panel
box
whisker
plot
rel
gut
abund
bpg
bacteria
yaxi
fecal
specimen
posttranspl
week
xaxi
subject
pair
abx
group
box
whisker
plot
line
repres
median
edg
box
plot
whisker
time
median
point
repres
outlier
p
valu
calcul
use
wilcoxon
signedrank
test
panel
e
box
whisker
plot
rel
gut
abund
bpg
bacteria
yaxi
fecal
specimen
posttranspl
week
xaxi
subject
pair
abx
group
receiv
antibiot
anaerob
coverag
box
whisker
plot
line
repres
median
edg
box
plot
whisker
time
median
point
repres
outlier
p
valu
calcul
use
wilcoxon
signedrank
test
week
pair
abx
group
rel
gut
abund
bpg
bacteria
significantli
lower
femal
group
male
group
median
vs
p
wilcoxon
ranksum
test
figur
significantli
lower
steroid
mainten
group
steroid
free
group
median
vs
p
wilcoxon
ranksum
test
figur
signific
associ
rel
gut
abund
bpg
bacteria
age
greater
year
old
african
american
race
induct
therapi
kidney
function
month
post
transplant
figur
f
evalu
whether
rel
gut
abund
bpg
bact
studi
report
one
first
descript
butyrateproduc
gut
bacteria
time
kidney
transplant
popul
data
reveal
antibiot
anaerob
coverag
associ
decreas
rel
gut
abund
bpg
bacteria
data
also
support
relationship
high
rel
gut
abund
bpg
bacteria
less
risk
develop
respiratori
import
note
allogen
hsct
subject
much
higher
proport
patient
less
rel
gut
abund
bpg
bacteria
kidney
transplant
recipi
studi
vs
respect
specul
differ
like
higher
number
antibiot
given
allogen
hsct
popul
studi
found
analys
addit
use
cutoff
rel
gut
abund
bpg
bacteria
util
allogen
hsct
recipi
popul
notabl
signific
differ
proport
hsct
recipi
proport
kidney
transplant
recipi
less
rel
gut
abund
bpg
bacteria
whether
cutoff
also
relev
kidney
transplant
popul
unknown
order
address
concern
evalu
bottom
quartil
cutoff
well
median
cutoff
find
associ
high
rel
gut
abund
bpg
bacteria
decreas
risk
respiratori
despit
limit
preliminari
studi
provid
one
first
descript
bpg
bacteria
kidney
transplant
recipi
earli
kidney
transplant
find
antibiot
anaerob
coverag
associ
decreas
rel
gut
abund
bpg
bacteria
also
report
associ
rel
gut
abund
bpg
bacteria
risk
develop
respiratori
viral
infect
kidney
transplant
recipi
result
preliminari
natur
requir
replic
larger
cohort
kidney
transplant
recipi
particular
report
trend
toward
signific
associ
rel
gut
abund
bpg
bacteria
cmv
viremia
would
need
valid
cmv
viremia
find
well
cmv
diseas
studi
examin
rel
gut
abund
bpg
bacteria
futur
studi
examin
absolut
gut
abund
bpg
bacteria
andor
fecal
butyr
concentr
may
provid
insight
relationship
bpg
bacteria
develop
viral
complic
nevertheless
find
confirm
data
support
therapeut
option
form
modul
gut
microbiota
decreas
viral
infect
rate
thank
nation
institut
allergi
infecti
diseas
research
support
via
nih
grant
ai
jrl
ai
ms
author
manuscript
follow
compet
interest
disclos
egp
receiv
speaker
honoraria
bristol
myer
squibb
celgen
sere
therapeut
medimmun
novarti
fer
pharmaceut
inventor
patent
applic
entitl
method
composit
reduc
clostridium
difficil
infect
enti
